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E-mail address: k.bradshaw4@btinternet.com (K. BIn normal subjects the later part of the cone a-wave to a brief ﬂash increases in amplitude after 50–
100 ms darkness due to a contribution from secondary hyperpolarising cells. We recorded these
responses along with clinical ON and OFF ERGs in patients with inner retinal dysfunction to see if this
part of the a-wave is affected. Patients with autoimmune-like retinopathy and CSNB2 had abnormal
ON and OFF responses but the a-wave increased in amplitude in the dark as in normals. Conversely,
the OFF-response was normal in CSNB1 but the a-wave did not increase in the dark. Contrary to expec-
tation these results show some hyperpolarising cell function in autoimmune-like disease and CSNB2 and
some OFF-pathway abnormality in CSNB1. The a- and d-wave are needed to assess OFF-pathway
function.
 2010 Elsevier Ltd. All rights reserved.1. Introduction
Several studies in non-human primate and normal human vol-
unteers have established that post receptoral cells make a signiﬁ-
cant contribution to the later part of the light adapted a-wave of
the cone-driven ERG (Bush & Sieving, 1994; Friedburg, Allen, Ma-
son, & Lamb, 2004; Hood & Birch, 1993, 1995; Robson, Saszik,
Ahmed, & Frishman, 2003; Paupoo, Mahroo, Friedburg, & Lamb,
2000). In non-human primates intra-vitreal application of pharma-
cological agents that block activity of inner retinal neurones sug-
gest that the responses of hyperpolarising bipolar cells (HBCs)
may summate with the later part of the cone photoreceptor com-
ponent of the ERG a-wave but a contribution from horizontal cells
(HCs) cannot be excluded (Bush & Sieving, 1994; Robson et al.,
2003). The contribution of these post-receptoral mechanisms can-
not be identiﬁed clearly in light adapted human ERG a-waves re-
corded under standard ERG procedures such as those
recommended for clinical ERG studies (Marmor et al., 2009). How-
ever, a post-receptoral contribution to the cone-driven a-wave can
be identiﬁed in the normal human ERG response to high energy
stimuli, especially when presented against a bright background
(Friedburg, Thomas, & Lamb, 2001; Hood & Birch, 1993; Paupoo
et al., 2000). Further studies in both human subjects and inll rights reserved.
House, Farm Lane, Thriplow,
radshaw).non-human primate showed that this post-receptoral component
can also be revealed more clearly in the response to low as well
as high energy stimuli if the stimulus is delivered after brieﬂy sup-
pressing a rod-saturating background light (Bradshaw, 2007; Rob-
son et al., 2003). Parametric studies showed that the cone a-wave
increased in amplitude after a brief period of darkness, reaching a
maximum after a 75–100 ms dark period and the increase was pro-
portionately greater at later times of the a-wave (typically at times
later than 8 ms). It was suggested that the increase in amplitude
was due to the contribution of secondary hyperpolarising cells that
were suppressed by relatively weak background adapting lights
and which recovered their sensitivity very rapidly in the dark.
If, as suggested, secondary hyperpolarising neurones contribute
signiﬁcantly to the later part of the cone a-wave it should be pos-
sible to obtain speciﬁc evidence for this in patients with disease
that is thought to speciﬁcally affect only depolarising bipolar cells
(DBCs), or diseases that affect both DBCs and secondary hyperpola-
rising neurones. In all forms of Congenital Stationary Night Blind-
nes (CSNB) the b-wave of the dark adapted ERG is severely
reduced in amplitude and inner retinal components of the light
adapted ERG (b-wave, OPs and PhNR) may also be altered, but
the photoreceptor-generated a-wave tends to be normal or near-
normal in amplitude (Allen et al., 2003; Bradshaw et al., 2004;
Miyake, Yagasaki, Horiguchi, Kawase, & Kanda, 1986; Miyake, Hor-
iguchi, Ota, & Shiroyama, 1987a; Sustar, Stirn-Kranjc, Hawlina, &
Brecelj, 2008; Tremblay, Laroch, & Becker, 1995). In one form of
the disease (CSNB1) abnormality appears to be conﬁned to
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but the OFF response to a long ﬂash is normal or even increased in
amplitude; in the other form of the disease (CSNB2) the OFF (d-
wave) and the ON b-waves are abnormal, indicating abnormality
of HBCs as well as DBCs (Langrova et al., 2002; Miyake, Yagasaki,
Horiguchi, & Kawase, 1987b; Sieving, 1993; Tremblay et al., 1995).
The contribution of secondary hyperpolarising neurones to the
cone a-wave can also be investigated in another group of patients
with ERG responses resembling those of patients with CSNB but
who have an acquired form of night blindness caused by autoim-
mune-related mechanisms. These retinopathies encompass the
better studied paraneoplastic syndromes such as cancer-associated
(CAR) and melanoma-associated (MAR) retinopathy (Alexander,
Fishman, Peachey, Marchese, & Tso, 1992; Berson & Lessell, 1988;
Milam et al., 1993; Singh, Milam, Shields, Potter, & Shields, 1995)
as well as a larger group of patients with similar symptoms but
without evidence of malignancy (Fishman, Alexander, Milam, &
Derlacki, 1996; Mizener et al., 1997; Peek, Verbraak, Coevoet, &
Kijlstra, 1998); for recent reviews see Audo, Robson, Holder, and
Moore (2008) Heckenlively, Aptsiauri, and Holder (2006). Patients
frequently present with recent, painless onset of night blindness,
abnormality of visual ﬁelds, photopsia and sometimes blurring of
central vision with minimal retinal changes. Symptoms are often
unilateral but the second eye may become involved at a later time.
ERGs are usually severely abnormal in the affected eye and the
changes are more often conﬁned to inner retinal responses. Serum
taken from patients with MAR typically show evidence of antibod-
ies against retinal cells and/or staining of inner retinal cells (Alex-
ander et al., 1992; Rush, 1993; Milam et al., 1993; Mizener et al.,
1997; Peek et al., 1998; Singh et al., 1995) which support the clin-
ical diagnosis and indicate that the clinical and ERG changes are
caused by a autoimmune mechanism. The antibodies are thought
to speciﬁcally affect DBCs because the ERG ON-pathway b-wave
is abnormal but the OFF-pathway d-wave is normal (Alexander
et al., 1992; Fishman et al., 1996; Lei, Bush, Milam, & Sieving,
2000). However, many patients without malignancy who ﬁt the
clinical picture have mixtures of antibodies directed against either
other unidentiﬁed retinal antigens or ones whose pathogenicity is
unknown (Fishman et al., 1996; Heckenlively et al., 2006; Mizener
et al., 1997; Peek et al., 1998). Moreover, an appreciable number of
healthy control subjects can manifest antiretinal antibodies
(Shimazaki, Jirawuthiworavong, Heckenlively, & Gordon, 2008).
Therefore, there is no deﬁnitive laboratory test and the diagnosis
of non-paraneoplastic retinopathy is made on the basis of the
typical cohort of presenting symptoms summarised above, normal
eye examination and severely abnormal ERGs indicating inner
retinal abnormality (Ferreyra et al., 2009; Heckenlively, Ferreyra,
& Janasundera, 2010; Jampol & Fishman, 2009).
We report ERG ﬁndings in two patients with unilateral symp-
toms and ERG changes suggesting autoimmune-like retinopathy
and in three patients with a diagnosis of CSNB, two having ERG re-
sponses typical of CSNB1 and the other of CSNB2. Standard ISCEV
clinical ERGs were recorded to conﬁrm that abnormality was con-
ﬁned to inner retina in all ﬁve patients. We also recorded ERG re-
sponses to a red stimulus ﬂash presented at various times after
brieﬂy extinguishing a rod-suppressing blue background light, as
described previously (Bradshaw, 2007), in order to investigate
the post-receptoral contribution to the cone a-wave. If secondary
hyperpolarising neurones make a signiﬁcant contribution to the
post-receptoral part of the cone a-wave, patients with CSNB1,
and possibly also those with autoimmune-like retinopathy, should
show a normal increase in a-wave amplitude when the stimulus is
presented after 50–100 ms of darkness. Conversly, patients with
CSNB2 should show minimal or no change in a-wave amplitude
under these test conditions. Surprisingly, the results were opposite
to expectation.2. Methods
2.1. ERG procedures
Full details of stimulation and recording procedures have been
given elsewhere (Bradshaw et al., 2004; Bradshaw, 2007) and are
repeated here in summary form.
2.1.1. Clinical ERGs
The stimuluswas aXenonﬂashdelivered via a integrating sphere
(Ganzfeld) to provide full ﬁeld illumination of the eyes. The ERGpro-
cedure incorporated rod and cone ERG responses recommended by
the International Society for Clinical Electrophysiology of Vision
(Marmor et al., 2009). After pupil dilation the eyes were dark adpat-
ed for 20 min and rod and mixed rod-cone (maximal) responses
were recorded to a dim and bright ﬂash respectively. The eyes were
then exposed continuously to a rod-suppressing white light
(25 ph.cd.s.m2 for 10 min after which cone ERGs were recorded to
a bright ﬂash, 30 Hz ﬂicker and a long-ﬂash (200 ms) stimulus.
2.1.2. Red ﬂash on blue background
Adapting and stimulus lights were delivered in a second cus-
tom-built Ganzfeld. The blue background light (Kodak Wratten
47B) from a tungsten halogen lamp was 39 sc.cd.m2 and passed
through an electronically operated shutter before entry into the
Ganzfeld. The stimulus was a 0.86 ph.cd.s.m2 red ﬂash (duration
44 uS) which is sufﬁcient to nearly saturate all ERG components
except the a-wave. Responses were recorded initially to a red ﬂash
presented against a steady background and then to the same stim-
ulus presented 0–300 ms after brief (100–300 ms) suppression of
the background ﬁeld. The subject’s eyes were exposed continu-
ously to the rod-suppressing background between experimental
conditions.
2.1.3. ERG data acquisition
ERGs were recorded from one eye by means of a DTL electrode
located in the lower conjunctival fornix. The reference electrode
was on the ipsilateral outer canthus and the ground electrode on
the forehead. The eye was anaesthetised with Benoxinate 1% and
the pupil dilated with Tropicamide 1%. The pupil diameter was be-
tween 8 and 8.5 mm for each subject. ERG data was acquired using
custom software running on a laboratory PC. The signals were
differentially ampliﬁed with a gain of 1000 over a bandwidth of
1–1000 Hz and digitized at a sample rate of 2 kHz with a resolution
of 12 bits. The sweep time was 200 ms for clinical ERGs and 100 ms
for the red ﬂash ERG responses. Eight to 16 responses were aver-
aged for each trial depending on signal quality and a pre-set volt-
age window allowed automatic rejection of sweeps contaminated
by artefact. At least two averaged responses were acquired for each
test condition and these were stored for off-line averaging and
measurement. The electronic shutters and ﬂash guns of the Ganz-
felds were also controlled by commands from the data aquisition
computer.
2.1.4. Measurement of ERG responses
The a-wave, rod-speciﬁc b-wave and d-wave were measured
from baseline to peak. The mixed rod-cone and the cone-speciﬁc
b-wave was easy to identify in normals and was measured from
the trough of the a-wave. The cone b-wave was measured in the
same way in patients but the rod-cone b-wave was abnormal
and it was difﬁcult to make reliable measurements because there
was no single, clearly deﬁned peak; amplitude was measured from
the trough of the a-wave to the maximum amplitude within the
time period 45–75 ms, which covers the range of peak latenies
for normal subjects.
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2.2.1. Normal
Clinical ERGs were compared with those of 26 normal volun-
teers. ERG responses to the red ﬂash procedures were compared
with those of eight normal volunteers. Informed consent was ob-
tained from each subject following detailed explanation of the pur-
pose and nature of the ERG procedure.
2.2.2. Patients
All the patients had been referred routinely for electrodiagnos-
tic studies as an aid to establishing an accurate clinical diagnosis.
P1. Presented ﬁrst at age 51 yrs with deteriorating vision. Col-
our vision, VA visual ﬁelds and eye examination were normal.
There was no relative afferent pupil defect and no family history
of eye disease. Red colours appeared desaturated in the left eye
and he was referred with a possible diagnosis of optic neuritis.
VEP responses were normal and he was re-referred for ERG testing
which showed very abnormal rod and cone inner retinal responses
for the left eye affecting both ON- and OFF-pathways. On further
questioning he reported that his vision with the left eye had been
poor but unchanged for about 30 yrs. Colours seen with the left eye
were relatively desaturated and in bright light objects lacked sharp
deﬁnition; he described the visual experience as like a white-out or
overexposed of the visual scene. He was photophobic in the left eye
and often used sun glasses. Vision was also poorer with the left eye
compared with the right eye in dim ligh. He was re-tested annually
for the following 4 yrs and there was no change in symptoms or in
ERG responses. Melanoma was positively excluded during this
period.
P2 Presented ﬁrst at age 52 yrs complaining that for 6–9 months
vision with the left eye was poor in low light and there was a blind
area in the upper left temporal quadrant. The visual ﬁeld of the left
eye was constricted on automated perimetry but the eye examina-
tion was essentially normal. He was referred with suspected subtle
retinal dystrophy and the ERG responses conﬁrmed unilateral
reduction of inner retinal responses affecting both rod and cone
pathways. On detailed questioning he reported that the onset of
symptoms was co-incident with a viral infection. Subjectively, his
central vision in the left eye was normal but he experienced de-
creased awareness of objects in peripheral vision. In dim light he
could not see objects clearly and in the dark he could see very little
or nothing with the left eye. In bright sunlight he, like P1, described
his vision with the left eye as like a over-exposure of the visual
scene – everything looked much brighter than with the right eye
and objects were indistinct. He was re-tested at variable intervals
for a period of 8 yrs during which time there was slight deteriora-
tion of ERG responses and subjective vision for the symptomatic
eye. The left disc became pale but there was no other fundus
abnormality. Malignancy was positively excluded.
Both patients had unilateral acquired disease and the cohort of
symptoms combined with severely abnormal unilateral inner reti-
nal abnormality were consistent with reported cases of autoim-
mune-related disease and this was the presumptive diagnosis
when they were discharged from routine follow-up. In the absence
of a deﬁnitive laboratory test we will refer to these patients as hav-
ing autoimmune-like disease. For brevity, especially in labelling
Figures, we use the abbreviation AI; this is distinct from the abbre-
viation AIR more commonly used in investigations of patients with
conﬁrmed autoimmune disease such as MAR.
P3. This was a 58 yr old man who presented with deteriorating
vision in the left eye. On examination he was found to be a moder-
ately strong myope with a cataract in the left eye and a history sug-
gesting amblyopia of the right eye. His discs, maculae, peripheral
retina and colour vision were normal but acuity was reduced to
6/60 right and 6/18 left. There was no known family history of rel-evant eye disease. On questioning he reported that he had always
had poor vision in the dark but this had been non-progressive and
had never been investigated. He was referred for ERG testing which
showed normal rod and cone a-waves, very reduced amplitude
b-waves, absence of OPs and an electro-negative waveform to a
bright ﬂash.
P4. This male patient presented ﬁrst age 24 yrs with nystagmus,
left amblyopia and a history of night blindness. His brother also
had poor vision in the dark and both showed normal rod and cone
ERG a-waves, severely reduced amplitude b-waves, absent dark
adapted OPs and an electro-negative waveform to a bright stimu-
lus ﬂash. The eye examination was normal. On re-testing 9 yrs la-
ter, at the time of this study, there had been no deterioration in
either his symptoms or ERG responses.
A diagnosis of XLCSNB was made in both cases and the ERG re-
sponses suggested CSNB1-type disease (see Results).
P5. This male patient ﬁrst presented age 26 yrs with an essen-
tially normal eye examination, intermittent nystagmus and moder-
ately strong myopia. He was tested along with his maternal
grandfather and both showed normal rod and cone ERG a-waves
but sub-normal b-waves. The dark adapted OPs were normal
amplitude but cone OPs were absent. The ERG response to 30 Hz
ﬂicker was abnormally low amplitude and had a double peaked
waveform. He was re-tested age 41 yrs at the time of this study
and ERG responses were unchanged. This combination of ERG fea-
tures suggested XLCSNB2-type disease (see results).3. Results
3.1. Clinical ERGs
Fig. 1 shows the clinical ERG response waveforms for a typical
normal volunteer (left panel) and for each patient. Fig. 2 shows
plots of response amplitude for each normal volunteer and for each
patient.
All rod and cone inner retinal ERG responses (b-wave, OPs,
30 Hz and PhNR) were severely abnormal in the symptomatic
eye of patients P1 and P2 with AI disease; these responses were
normal in the asymptomatic eye. Rod a-waves to bright ﬂashes
were normal in both patients. The cone a-wave was altered in both
patients but peak amplitude was normal in one and only margin-
ally reduced in the other patient compared with responses of nor-
mal subjects. These responses were typical of ERGs in patients with
inner retinal disease. The long-ﬂash ERG d-wave was also abnor-
mal in both patients indicating OFF as well as ON-pathway
abnormality.
The rod-speciﬁc b-wave and bright ﬂash b-wave were severely
reduced in amplitude and the OPs were absent in the ERG re-
sponses of patients P3 and P4. The rod a-wave was normal in
one and only marginally reduced in the other patient so that the
response to a bright ﬂash had a negative-waveform. Cone a- and
b-wave amplitudes were normal but the form of the response
was altered because of the absence of one or more OPs. The cone
PhNR was also severely reduced in amplitude but the 30 Hz re-
sponse and the long-ﬂash cone d-wave was normal in both pa-
tients. These results conﬁrm normal photoreceptor responses but
abnormal inner retinal function conﬁned to the ON-pathway and
are typical of reported ﬁndings in CSNB1.
Rod and cone a-wave amplitudes were normal in patient P5.
Rod b-waves to dim and bright ﬂashes were very reduced in ampli-
tude but responses were not as severely affected as those of pa-
tients P3 and P4 and the dark adapted OPs were preserved. The
cone b-wave amplitude was at the lower limit of the range of val-
ues for normal subjects but the light adapted OPs and the PhNR
were not identiﬁable. The 30 Hz ﬂicker response was severely
Normal AI P1 AI P2
CSNB1 P3 CSNB1 P4 CSNB2 P5
Fig. 1. ISCEV standard ERG responses. Bottom to top: Dark adapted Rod response; dark adapted Maximal response; light adapted response to ISCEV SF stimulus; 30 Hz ﬂicker;
ON-OFF ERGs to 200 ms stimulus ﬂash. Responses P1 and P2 show ERGs for asymptomatic eye (solid line) and symptomatic eye (broken line).
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Fig. 2. Scatterplots of ISCEV ERG amplitudes (in microvolts) for responses labelled on vertical axis of each graph. Columns left to right: normal age-matched volunteers; two
patients with autoimmune retinopathy (AI), two patients with CSNB1 and one patient with CSNB2.
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to a long-ﬂash stimulus was compromised by the patients photo-
phobia and the response was technically too poor to yield speciﬁc
information about OFF-pathway function. However, all ERG re-
sponses to short ﬂash stimuli were typical of reported ﬁnding in
CSNB2 and the patients photophobia was also consistent with this
form of the disease.
3.2. ERG responses to a red ﬂash stimulus
Fig. 3 shows the ERG responses to a brief red ﬂash. The top row
shows the full waveform of the ERG response recorded against a
steady background. The lower four traces plotted with a solid line
is the same a-wave replicated down the page and on an expanded
time scale. A previous study of these responses in normal subjects
showed that the most signiﬁcant changes in a-wave amplitude and
waveform occur when the stimulus is presented 0–100 ms after
brieﬂy extinguishing a rod-suppressing background (Bradshaw,
2007). The broken-line traces show the responses recorded when
the stimulus was presented 25, 50, 75 and 100 ms after extinguish-
ing the background (top to bottom on expanded x-axis plots).
Both AI patients show very reduced b-wave amplitude and an
absence of OPs, PhNR and i-wave; the a-wave was also reduced
in amplitude compared with the normal subject. However, both
patients showed an increase in a-wave amplitude in the dark with
maximal amplitude response for dark periods of 50–75 ms. Both
patients with CSNB1 also show reduced amplitude inner retinal re-
sponses but these were less severely affected than equivalent re-
sponses of the AI patients; the a-wave was also slightly reduced
in amplitude for P4 but not for P3. A-wave amplitude for these
two patients showed minimal change after a brief period of dark-
ness. The ERG response for the CSNB2 patient showed a normal
a-wave and clearly deﬁned b-wave but reduced amplitude PhNR
and OPs. However, the a-wave increased in amplitude in the dark
similar to normal subjects. The a-wave peak was also prolonged
in latency in the light for all three patient groups; peak latency
in the dark did not change for the AI or CSNB1 patients but became
even more prolonged for the CSNB2 patient.The reduced amplitude a-waves for the AI and one CSNB1 pa-
tient raises the question as to whether this is due to cone photore-
ceptor abnormality or to change to the late post-receptoral
component of the a-wave. Therefore we measured the amplitude
of the a-wave at 8 ms as well as at response peak. Fig. 4 shows
the plots of a-wave amplitude recorded to a red ﬂash presented
against a steady background. The amplitude of the a-wave at
8 ms as well as at peak time was signiﬁcantly smaller than normal
for both AI patients conﬁrming a sub-normal cone photoreceptor
response. A-wave amplitude at 8 ms was at the lower limit of the
normal range for both CSNB1 patients but was normal for the
CSNB2 patient.
The peak a-wave amplitudes recorded against a steady back-
ground and shown in the right panel of Fig. 4 were re-plotted on
a compressed y-axis and are shown in the left panel of Fig. 5; the
maximal peak amplitude responses recorded after 50–100 ms
darkness are shown in the right panel of Fig. 5. Every normal sub-
ject showed a substantial increase in peak a-wave amplitude in the
dark; the increase ranged from 150% to 238%. A-wave amplitude
increased by 338% and 400% for the AI patients; this relative in-
crease was greater than that seen for any of the normal subjects
and peak amplitude in the dark was normal for P1 and at the lower
limit of normal for P2. A-wave amplitude for the CSNB2 patient
(P5) also increased in the dark by 159%; the relative increase and
maximal amplitude in the dark were both within the range of nor-
mal values. Conversely, both CSNB1 patients showed minimal in-
crease (145% and 150%) and maximal amplitudes in the dark
were also at or below those of the normal volunteers.
Fig. 6 shows peak a-wave amplitude plotted against stimulus
delay (time in dark after brieﬂy extinguishing the background)
for the full range of stimulus delay times studied. Mean amplitudes
for the eight normal subjects are shown in the left panel and the
responses for each subject were of a similar form with a maximal
peak amplitude recorded when the stimulus was delayed by
75 ms or 100 ms. The responses for each patient are plotted sepa-
rately in the three panels to the right. Responses were measured
for stimulus delays extending from 0 ms to 300 ms for all subjects
except the CSNB2 patient; for the latter patient measurements
Normal AI P1 AI P2
CSNB1 P3 CSNB1 P4 CSNB2 P5
Fig. 3. ERG responses to a 0.86 ph.cd.s.m2 red ﬂash. Top panels show the full ERG responses recorded when the stimulus was presented against a steady blue background.
Lower panel solid traces show the same response, replicated down the page, on an expanded time and amplitude scale; the broken lines show the response to the same
stimulus when presented 25 ms, 50 ms, 75 ms and 100 ms (top to bottom) after brieﬂy extinguishing the blue background.
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Fig. 4. Scatterplot of cone a-wave amplitudes to a 0.86 ph.cd.s.m2 red ﬂash
presented agains a steady blue background (38 sc.cd.m2). Amplitude measured at
8 ms (left panel) and at response peak (right panel); note the different y-axis scales.
Fig. 5. Scatterplot of cone a-wave peak amplitudes to a 0.86 ph.cd.s.m2 red ﬂash.
Stimulus presented agains a steady blue background (left panel) or 75 ms after
brieﬂy extinguishing the background (right panel).
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because of clinic time constraints. The amplitude-response func-Fig. 6. A-wave peak amplitude when the stimulus was presented against a steady blu
extinguishing the background. Mean amplitude for eight normal volunteers (left panel)tion for both AI patients was comparable with that for the normal
subjects. The stimulus-response function for the CSNB2 patient
was also similar to normal over the 0–100 ms time period investi-
gated; the peak amplitude measurement for the response recorded
against a steady background (plotted as 50 ms on the x-axis) may
not be accurate because the form of this response was slightly dis-
torted by eye movement or blink artefact (see also the right panel
of Fig. 3). The stimulus-response function for CSNB1 patient P4 is
similar in form to that of normals, but with a much reduced max-
imal amplitude for a 100 ms stimulus delay. CSNB1 patient P3 does
not show a signiﬁcant, systematic change in amplitude with
increasing stimulus delay.4. Discussion
We recorded ERGs in patients with conﬁrmed inner retinal dis-
ease to speciﬁcally investigate the contribution of HBCs or other
secondary hyperpolarising neurones to the cone a-wave.
Two patients were diagnosed with autoimmune-like retinopa-
thy (AI) because their unilateral symptoms and ERG abnormality
were similar to reported cases of autoimmune-related disease
(Audo et al., 2008; Heckenlively et al., 2006); there is currently
no deﬁnitive laboratory test for the non-neoplastic forms of the
disease. Clinical ERGs of both patients showed severe abnormality
of all dark and light adapted inner retinal responses. Because the
d-wave was abnormal, indicating an OFF-pathway defect, we did
not expect the cone a-wave to a red ﬂash to increase in the dark
but in fact the response of both patients increased substantially
after 50–100 ms darkness (see Fig. 3). The maximal amplitude in
the dark was comparable with that of normal subjects in onee background (shown as time 50 ms) or when presented 0–300 ms after brieﬂy
and for each patient.
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(see Fig. 5). One factor that may contribute to an explanation for
the observed change is that the later part of the a-wave is un-
masked when the b-wave is reduced or absent. The observation
that the cone a-wave peak is broader and persists longer before
being countered by positive polarity signals (Fig. 3) is consistent
with this view. We also considered the relative increase in ampli-
tude in the dark because the photoreceptor response (measured at
8 ms) was smaller than normal in one patient. Both patients
showed a greater-than-normal increase in amplitude in the dark
(330% and 400%) relative to the response recorded when there
was a steady background. These results indicate that the a-wave
receives a substantial continuing hyperpolarising cell contribution
in both patients.
If the patients symptoms are indeed caused by autoimmune-re-
lated disease, the abnormally low amplitude a-wave at 8 ms as
well as at peak in both patients provides new evidence that cone
photoreceptors must be affected in some patients with this dis-
ease. The abnormal d-waves (OFF-pathway) indicate that second-
ary hyperpolarising cells must also be affected, contrary to
previous evidence that circulating antibodies affect only DBCs
(Alexander et al., 1992; Fishman et al., 1996; Lei et al., 2000).
Two factors may account for these discrepancies. Firstly, OFF re-
sponses to long-ﬂash stimuli have not been recorded in some stud-
ies of autoimmune-related disease so HBC involvement cannot be
absolutely excluded. Secondly, clinical and ERG variations are
likely to occur given the variety of antigens and complex proteins
that may be involved (Adamus, Ren, & Weleber, 2004; Mizener
et al., 1997; Peek et al., 1998).
Abnormal OFF d-waves have been reported previously in larger
series of patients with CSNB2, indicating abnormality affecting sec-
ondary hyperpolarizing neurons as well as DBCs (Miyake et al.,
1987a; Langrova et al., 2002). Unfortunately the long-ﬂash ERG re-
sponses of our patientwith CSNB2were technically too poor to con-
ﬁrm that the OFF d-wave was abnormal but the preserved dark
adapted OPs and especially the light adapted ERG responses to a
brief ﬂashand to30 Hzﬂicker clearlydistinguish this formof thedis-
ease from CSNB1 (Allen et al., 2003; Bradshaw et al., 2004; Miyake
et al., 1987a; Sustar et al., 2008; Tremblay et al., 1995). Interestingly,
his ERG responses were as severely affected as those of our patients
withAI retinopathy. Abnormality of theOFF-pathway should reduce
or eliminate the hyperpolarising cell contribution to the cone
a-wave but again, contrary to expectation, the a-wave changed in
form and increased in amplitude in the dark and the maximal
amplitude was within the range of normal values (see Figs. 3 and
5). Therefore, our results provide new evidence for continuing
hyperpolarising cell function in CSNB2.
Our results in both AI and CSNB2 patients indicate a continuing
hyperpolarising cell contribution to the cone a-wave. This input
can be from HBCs or/and HCs. Previous studies have considered
HBCs the most likely candidate (Bush & Sieving, 1994; Robson
et al., 2003) but possible involvement of HCs should not be
ignored. Falk and Shiells (Falk & Shiells, 1986) provided direct
evidence for a HC contribution by showing that a negative polar-
ity signal remaining after application of APB had a time course
similar to that of HCs. It has also been shown that the afterpoten-
tial of A-type HCs in rabbit occurs concurrently with the PIII neg-
ative component of the ERG over a range of stimulus intensities,
implying that the initial potential of HCs may also contribute to
the ERG but are obscured by the b-wave (Hanitzsch, Karbaum, &
Lichtenberg, 1999). We cannot speculate further about why the
a-wave is unaffected in AI because the antigen involved and their
mechanism of action is not known. However, CSNB2 can be diag-
nosed with conﬁdence and causative mutations are known; this
allows us to tentatively propose a possible mechanism underlying
our results in CSNB2.CSNB2 is caused by a mutation of the CACNA1F gene and a
number of speciﬁc types of mutation have been identiﬁed (Boycott
et al., 2001; Peloquin, Rehak, Doering, & McRory, 2007). The way in
which these speciﬁc mutations affect retinal cell function is not
understood at the present time but some recently reported ﬁnd-
ings suggest a possible mechanism underlying our observed
changes to the cone ERG a-wave. The CACNA1F gene encodes the
alpha 1 F subunit in the Ca 1.4 voltage dependent calcium channel
(Doering, Peloquin, & McRory, 2007). Such channels control the re-
lease of the transmitter glutamate from photoreceptors to bipolar
and horizontal cells. In the nob2 mouse with a mutation in CAC-
NA1F the outer plexiform layer is disorganized with ectopic neu-
rites from rod bipolar and horizontal cells and compromised
cone pedicles (Chang et al., 2006; Doering et al., 2007). It has also
been shown that the F742C mutation, which also occur in humans
with CSNB2 (Peloquin et al., 2007), result in an active Ca-channel
but with altered features which enable a greater inﬂux of calcium
at any given voltage within the operating range of the photorecep-
tors. The dynamic range, however, of the photoreceptor is dramat-
ically reduced when compared with physiological conditions.
Perhaps very speciﬁc changes in the Ca 1.4 voltage dependent cal-
cium channel cause very special changes in hyperpolarising neu-
rons that reduces their response at light OFF but do not impair
the response at light ON so that there can be a normal increase
in the a-wave after a brief dark adaptation as described here.
Compared with CSNB2, CSNB1 is considered to be a model sys-
tem for studying exclusively ON-pathway abnormality in humans
(Khan et al., 2005; Langrova et al., 2002). CSNB1 can be caused
by mutations in NYX, GRMG6 and TRPM1 genes (Bech-Hansen
et al., 2010; Claassen et al., 2010). The NYX gene is responsible
for the expression of the protein Nyctalopin (Bech-Hansen et al.,
2000; Pusch et al., 2000). Nyctalopin is necessary for the expres-
sion and function of the TRPM1 channel (Bellone et al., 2008), a
special cation channel gated by the mGluR6-Nyctalopin signalling
cascade in ON-bipolar cells (Claassen et al., 2010). This channel has
been found at rod bipolar cells (Gregg et al., 2007) and at cone ON-
bipolar cells but spares certain types of cone ON-bipolar cells
(Gregg et al., 2007; Morgans et al., 2009). Pharmacological suppres-
sion of ON-pathway function in non-human primate has been
shown to cause ERG changes that mimic those seen in CSNB pa-
tients with the NYX gene mutation (Khan et al., 2005). Given this
strong evidence for selective ON-pathway abnormality we ex-
pected that the a-wave would increase in amplitude in the dark
in CSNB1 similar to normal subjects. In fact our patients did not
show a signiﬁcant change to a-wave amplitude or waveform to a
red ﬂash presented after a short period of darkness compared with
responses recorded to the same stimulus on a steady background.
This unexpected ﬁnding therefore provides evidence that there can
be an OFF-pathway defect in CSNB1.
Before speculating on possible mechanisms underlying these a-
wave results it will be useful to brieﬂy summarise what is known
about the cellular origin of the cone-driven a- and d-waves; for an
authoratative review see Frishman (2006). The d-wave is the pri-
mary response used in clinical ERGs to determin whether or not
there is abnormality of the OFF-pathway. It is a positive-going
deﬂection recorded at light offset under photopic conditions and
consists of a initial rapid rise to a sharply deﬁned peak followed by
a series of smaller oscillations on the descending limb of the re-
sponse (see normal waveform shown in Fig. 1); there is also a later,
longer-lasting slow phase which is not normally recorded in its full
extent in clinical ERG studies. Pharmacological dissection studies
have shown that the initial fast rising phase receives a strong contri-
bution from the depolarising response at light offset of cone HBCs/
HCs (Bush& Sieving, 1994;Ueno et al., 2006). It also receives a signal
of opposite polarity from the hyperpolarising response of DBCs at
light offset (Ueno et al., 2006). There is also a small but signiﬁcant
K. Bradshaw, R. Hanitzsch / Vision Research 50 (2010) 2505–2514 2513contribution from inner retinal neurones to the initial rapid phase
and theoscillatory components. The conephotoreceptor contributes
mainly to the late slow phase rather than the initial rapid phase. The
conea-wave is anegative-goingpotential recordedat light onset and
is truncated by the positive-going b-wave generated by DBCs in the
ON-pathway. The initial rapid phase of the a-wave reﬂects the cone
photocurrent. Removal of the b-wave reveals a later, more slowly
recovering portion called the later receptor potential which is now
considered to reﬂect the recovery phase of the receptor photore-
sponse. Pharmacological dissection studies in non-human primate
(Bush&Sieving, 1994; Robsonet al., 2003) andparametric ERG stud-
ies in human (Bradshaw, 2007; Friedburg et al., 2004) have also re-
vealed a later slow post-receptoral signal that is also negative in
polarity; this is thought to be generated by hyperpolarising cells
post-synaptic to the photoreceptor in the cone OFF-pathway. This
signal sums with the cone photocurrent and it is the component
whichwe have investigatedwith the red ﬂash procedures in our pa-
tients. Therefore, themain contributor to the later part of the cone a-
wave is from secondary hyperpolarising neurones.
We may now consider the anomalous a-wave results in our pa-
tients with CSNB1. The initial fast part of the d-wave is, as we have
seen, the sumof responses of depolarising (ON-pathway) andhyper-
polarising (OFF-pathway)neurones. If a defect of the TRPM1channel
severely impairs the function of depolarising neurones, the fast part
of the d-wave will be determined to a greater extent by hyperpola-
rising neurones and so the d-wave should be enlarged. However, the
majority of studies, including ours, report normal d-waves in CSNB1
(Langrova et al., 2002; Miyake et al., 1986; Sustar et al., 2008). This
can only happen if the OFF-pathway is impaired to some extent. A
larger-than-normal d-wave has been reported in a patient with
CSNB1 (Khanet al., 2005) and inapatientwithautoimmune-like ret-
inopathy (Fishman et al., 1996) but the incidence of abnormal d-
waves cannot be assessed accurately because some studies present
results in only a small number of patients and there is often a ab-
sence of quantitative d-wave amplitude data. Also, variability in
the genetic defects may cause some variability between families
with CSNB1. In the future it may beworthwhile to search for TRPM1
channels andpossibledefects inhyperpolarisingneuronesandespe-
cially in axon terminals of B-typeHCswhich receive input from rods
and establish an intense network in the outer retina (Dowling, 1987;
Peichl, Sandmann,&Boycott, 1998;Reitsamer, Pﬂug, Franz,&Huber,
2006). A defect in HCs could possibly explain the absence of change
in the dark to the post-receptoral part of the cone a-wave in ERGs
which do not have a enlarged d-wave. Secondary changes affecting
responses of neurones later in the OFF-pathway may also affect
the ERG.
In contrast, the later part of the cone a-wave may receive input
mainly from secondary hyperpolarising neurones and this differ-
ence may underlie the striking dissociation between our d- and
a-wave results. So there may be no signiﬁcant increase in cone a-
wave amplitude in the dark indicating some impairment of sec-
ondary hyperpolarising neurones but the d-wave can be of normal
size because it is an interference of depolarising and hyperpolaris-
ing neurones. That is the case in our patients with CSNB1 and we
must conclude that CSNB1 is not a disease that affects only ON-
pathway function; secondary hyperpolarising neurones may also
be impaired. Another possibility is that there can be impairment
of secondary hyperpolarizing neurons at light OFF but a substantial
reaction at light ON. In the ERG there is then a reduced d-wave but
an increase in the a-wave at light ON after a short period of dark
adaptation. This is the case in our patients with CSNB2 and AI.
5. Conclusions
The results in all three groups of patients were contrary to our
expectation. Our cone a-wave results provide new evidence for aOFF-pathway defect in CSNB1 and AI retinopathy and for contin-
uing hyperpolarising cell function in CSNB2. In AI and CSNB2 the
reduced d-wave indicates impaired secondary hyperpolarising cell
function at light OFF but the increase in cone a-wave amplitude in
the dark indicates a substantial reaction of hyperpolarising cells at
light ON. In our patients with CSNB1 the d-wave was in the normal
range and the cone a-wave did not increase in the dark indicating
impaired secondary hyperpolarising cells at light ON and OFF. The
defect in CSNB1 may be due to abnormality of a speciﬁc synaptic
mechanism affecting HBCs, but attention should also be given to
possible involvement of HCs or to secondary changes affecting
neurones later in the OFF-pathway. The strong dissociation be-
tween the d- and a-wave results indicates that the dark adapted
a-wave after extinguishing a background light can provide impor-
tant additional information about secondary hyperpolarising cell
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